In a welcome move, Tenet Healthcare stock saw its Relative Strength Rating improve from 67 to 77 on Thursday.
When To Sell Stocks To Lock In Profits And Minimize Losses
IBD's unique RS Rating tracks market leadership by using a 1 (worst) to 99 (best) score that indicates how a stock's price action over the trailing 52 weeks matched up against all other stocks.
Decades of market research reveals that the market's biggest winners often have an 80 or higher RS Rating as they launch their largest climbs. See if Tenet Healthcare stock can continue to rebound and clear that threshold.
Is Tenet Healthcare Stock A Buy?
Tenet Healthcare stock recently reclaimed its 200-day moving average. Now is not an ideal time to jump in since it isn't near a proper buy zone, but see if the stock manages to offer and clear a proper buy point. Given the current market uncertainties, IBD recommends a cautious market exposure of 20-40%.
Earnings grew 35% last quarter, up from 28% in the prior report. Revenue also increased, from -6% to -3%.
Tenet Healthcare stock holds the No. 1 rank among its peers in the Medical-Hospitals industry group. Tenet Healthcare and Select Medical Holdings are also among the group's highest-rated stocks.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
